Description

Investments in Research and Development (R&D) is the key to sustaining innovation and promoting growth in the healthcare industry. Between 2007 and 2012, global investment in R&D in the industry took a detour from US and Europe towards Asia-Pacific (APAC) countries, primarily targeting Australia, Singapore, and South Korea. This research report presents a high-level chronicling of the events and transitions that have led to this trend—the emergence of APAC as a prominent R&D hub.